Alpha Omega Peptide is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act
AOD-9604 has some clinical trial data, though it has not achieved widespread regulatory approval for weight loss
And some products on the market test far below 85% purity
This occurs through the direct impact of the peptide on body fat tissue, whereby it activates the beta-3 adrenergic receptor(s) involved in the fat-burning process within the body
Muscle preservation during fat loss One of the most significant concerns with any fat loss protocol is muscle loss
It is a well-characterized, mechanistically specific peptide with a 30-year research history, a strong clinical safety record from formal trials, and modest but real efficacy data from 12-week studies